The precise role of CCL21 in the activation and impairment of proper T cells during SARS-CoV-2 infection remains unclear; thus, a subsequent study may define the precise role of this chemokine post-SASR-CoV-2 infection. This evidence concerns the gene CCL21 and COVID-19.